We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
Cap. Flow
+$17.6M
Cap. Flow %
3.01%
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 14.7%
3 Healthcare 14.64%
4 Consumer Staples 12.4%
5 Miscellaneous 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STE icon
151
Steris
STE
$22.7B
$1.16M 0.2%
7,580
+3,600
+90% +$528K
LSI
152
DELISTED
Life Storage, Inc.
LSI
$1.15M 0.2%
+15,956
New +$1.14M
JNPR
153
DELISTED
Juniper Networks
JNPR
$1.15M 0.2%
+46,700
New +$1.15M
ENPH icon
154
Enphase Energy
ENPH
$5.19B
$1.15M 0.2%
43,872
-53,894
-55% -$1.23M
TDY icon
155
Teledyne Technologies
TDY
$29B
$1.14M 0.2%
+3,300
New +$1.11M
MRK icon
156
Merck
MRK
$369B
$1.14M 0.19%
+13,100
New +$1.08M
CVNA icon
157
Carvana
CVNA
$53.3B
$1.13M 0.19%
61,500
-51,355
-46% -$859K
DIA icon
158
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
$1.13M 0.19%
3,970
+3,170
+396% +$873K
FIVN icon
159
FIVE9
FIVN
$2.58B
$1.13M 0.19%
+17,212
New +$1.05M
HIG icon
160
Hartford Financial Services
HIG
$37.3B
$1.12M 0.19%
18,500
+5,300
+40% +$318K
PAYX icon
161
Paychex
PAYX
$45B
$1.12M 0.19%
13,200
+2,277
+21% +$192K
BIO icon
162
Bio-Rad Laboratories Class A
BIO
$10.4B
$1.11M 0.19%
3,004
-3,300
-52% -$1.16M
KEYS icon
163
Keysight
KEYS
$55.5B
$1.11M 0.19%
10,800
-20,200
-65% -$2.07M
OC icon
164
Owens Corning
OC
$11.4B
$1.11M 0.19%
+17,000
New +$1.09M
INFY icon
165
Infosys
INFY
$48.2B
$1.1M 0.19%
+107,100
New +$1.08M
MTZ icon
166
MasTec
MTZ
$20.2B
$1.08M 0.18%
16,815
-6,300
-27% -$415K
UHS icon
167
Universal Health Services
UHS
$10.2B
$1.04M 0.18%
7,261
+2,725
+60% +$388K
EWJ icon
168
iShares MSCI Japan ETF
EWJ
$22.7B
$1.04M 0.18%
+17,500
New +$1.03M
JBL icon
169
Jabil
JBL
$32.7B
$1.03M 0.18%
25,045
+3,800
+18% +$146K
MAS icon
170
Masco
MAS
$14.4B
$1.03M 0.18%
+21,500
New +$977K
DVA icon
171
DaVita
DVA
$11.4B
$1.03M 0.18%
+13,700
New +$909K
LYFT icon
172
Lyft
LYFT
$6.57B
$1.03M 0.18%
23,900
-12,200
-34% -$535K
SPR
173
DELISTED
Spirit AeroSystems
SPR
$1.02M 0.17%
13,941
+10,841
+350% +$894K
RTN
174
DELISTED
Raytheon Company
RTN
$1.01M 0.17%
+4,600
New +$972K
TDG icon
175
TransDigm Group
TDG
$65.6B
$1M 0.17%
1,791
-1,202
-40% -$658K

Similar funds

Bayesian Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.

  • Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
  • Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
  • Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
  • Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
  • Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
  • Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
  • Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.

Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.